v3.23.1
Integration and Restructuring Plans (Tables)
3 Months Ended
Mar. 31, 2023
Allergan integration plan  
Restructuring charges  
Summary of charges associated with integration plan The following table summarizes the charges (benefits) associated with the Allergan acquisition integration plan:
Three months ended
March 31,
(in millions)20232022
Cost of products sold$14 $31 
Research and development— 
Selling, general and administrative44 70 
Total charges$58 $110 
Summary of cash activity in the restructuring reserve The following table summarizes the cash activity in the recorded liability associated with the Allergan integration plan for the three months ended March 31, 2023:
(in millions)
Accrued balance as of December 31, 2022
$107 
Charges58 
Payments and other adjustments(69)
Accrued balance as of March 31, 2023$96 
Other restructuring  
Restructuring charges  
Summary of cash activity in the restructuring reserve The following table summarizes the cash activity in the restructuring reserve for the three months ended March 31, 2023:
(in millions)
Accrued balance as of December 31, 2022$176 
Restructuring charges17 
Payments and other adjustments(24)
Accrued balance as of March 31, 2023$169